Emisphere Technologies Inc (EMIS) - Financial and Strategic SWOT Analysis Review

May 2017 | 50 pages | ID: EEAA64085F8EN
GlobalData

Abstracts

Emisphere Technologies Inc (EMIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Emisphere Technologies Inc (Emisphere) is a specialty pharmaceutical and drug delivery company. The company in partnership with global pharmaceutical companies develops novel oral formulations of existing injectable bio-pharmaceutical products, besides new chemical entities, using its Eligen technology. Its lead product Eligen B12, is the first and only once-daily oral prescription medical food approved in the US for treatment of vitamin b12 deficiency. The product is sold through a range of distributors, sellers, and other sources. Emisphere also uses its proprietary Eligen technology to produce novel oral formulations of therapeutic agents. The company’s product pipeline includes prescription drugs and medical food products that are being developed in partnership or internally. Emisphere is headquartered in Roseland, New Jersey, the US.

Emisphere Technologies Inc Key Recent Developments

May 12,2017: Emisphere Reports First Quarter 2017 Financial Results
Mar 29,2017: Emisphere Reports Fourth Quarter and Full Year 2016 Financial Results
Dec 09,2016: Emisphere Restructures Debt Agreements, Providing Greater Stability for Business Growth and Expansion
Nov 14,2016: Emisphere Reports Third Quarter 2016 Financial Results
Aug 15,2016: Emisphere Reports Second Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Emisphere Technologies Inc - Key Facts
Emisphere Technologies Inc - Key Employees
Emisphere Technologies Inc - Key Employee Biographies
Emisphere Technologies Inc - Major Products and Services
Emisphere Technologies Inc - History
Emisphere Technologies Inc - Company Statement
Emisphere Technologies Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Emisphere Technologies Inc - Business Description
Emisphere Technologies Inc - Corporate Strategy
Emisphere Technologies Inc - SWOT Analysis
SWOT Analysis - Overview
Emisphere Technologies Inc - Strengths
Emisphere Technologies Inc - Weaknesses
Emisphere Technologies Inc - Opportunities
Emisphere Technologies Inc - Threats
Emisphere Technologies Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Emisphere Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Emisphere Technologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Emisphere Technologies Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 12, 2017: Emisphere Reports First Quarter 2017 Financial Results
Mar 29, 2017: Emisphere Reports Fourth Quarter and Full Year 2016 Financial Results
Dec 09, 2016: Emisphere Restructures Debt Agreements, Providing Greater Stability for Business Growth and Expansion
Nov 14, 2016: Emisphere Reports Third Quarter 2016 Financial Results
Aug 15, 2016: Emisphere Reports Second Quarter 2016 Financial Results
May 16, 2016: Emisphere Reports First Quarter 2016 Financial Results
Mar 29, 2016: Emisphere Reports Fourth Quarter and Full Year 2015 Financial Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Emisphere Technologies Inc, Key Facts
Emisphere Technologies Inc, Key Employees
Emisphere Technologies Inc, Key Employee Biographies
Emisphere Technologies Inc, Major Products and Services
Emisphere Technologies Inc, History
Emisphere Technologies Inc, Key Competitors
Emisphere Technologies Inc, Ratios based on current share price
Emisphere Technologies Inc, Annual Ratios
Emisphere Technologies Inc, Annual Ratios (Cont.1)
Emisphere Technologies Inc, Interim Ratios
Emisphere Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Emisphere Technologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Emisphere Technologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Emisphere Technologies Inc, Performance Chart (2012 - 2016)
Emisphere Technologies Inc, Ratio Charts
Emisphere Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Emisphere Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Insmed Inc
Gilead Sciences Inc
Bristol-Myers Squibb Company
Astellas Pharma Inc
Allergan Plc